09989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 3.76
−9.51%Forward multiples
Based on analyst estimates
- P/E forward
- 10.97x
- P/E 2026E
- 7.58x
- P/E 2027E
- 7.15x
- P/E 2028E
- 6.49x
- P/S forward
- 1.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.03x
- PEG TTM
- 0.21x
- Price / book
- 0.40x
- Price / sales
- 0.90x
- Price / cash flow
- 3.15x
Enterprise value
- Enterprise value
- HKD 4.8B
- EV / sales
- 0.78x
- EV / EBITDA
- 11.69x
- EV / EBIT
- 21.46x
- Market cap
- HKD 5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026